¾ÆÆ²¶õƼī °ÔÀÓ¸®Æ÷Æ® - ¾ÆÆ²¶õƼīÀÇ ¸ðµçÁ¤º¸

Àüü°Ë»ö :

 

¡¤ ¾ÆÆ²¶õƼī °ÔÀÓÁ¤º¸
  ¾ÆÄ« ¸®Æ÷Æ®
  Á¤º¸¿Í ºÐ¼®
  ¾ÆÄ« Áö½ÄIN
  À¯ÀúµéÀÇ ÆÁ°ú ³ëÇÏ¿ì
---------------------
¡¤ ¾ÆÆ²¶õƼī µ¿¿µ»ó
---------------------
¡¤ Ä¿¹Â´ÏƼ
  ÀÚÀ¯°Ô½ÃÆÇ
  ³»°¡ÂïÀº ¸íÀå¸é
  ¾ÆÀÌÄܼ¥
  ³¡¸»ÀÕ±â ÄôÄôµû

  FAQ
  °ÇÀÇ/Á¦º¸ÇÕ´Ï´Ù
¾î¶² ¹«±â(ij¸¯ÅÍ)°¡ ¸¾¿¡ µì´Ï±î?
    ±Û¾´ÀÌ : ÇØÁؼÛÈ¿     ³¯Â¥ : 25-05-16      Á¶È¸ : 30    
    Á¦¸ñ : ¹Ù´ÙÀ̾߱âPC¹öÀü 38.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü
   http://71.rus795.top (4)
   http://9.rkt365.top (4)

¹Ù´ÙÀ̾߱âPC¹öÀü 46.rzz625.top ¹Ù·Î°¡±â ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 12.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 21.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 15.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 42.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 11.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 62.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 82.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 30.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 79.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü



¹Ù´ÙÀ̾߱âPC¹öÀü 57.rzz625.top ¹Ù´ÙÀÌ¾ß±â ²Ç¸Ó´Ï È¯Àü

¹Ù·Î°¡±â go !! ¹Ù·Î°¡±â go !!

Ȳ±Ý¼º°ÔÀÓ°ø·«¹ý ÃֽŹٴÙÀ̾߱â°ÔÀÓ Ä«Áö³ë ½½·Ô¸Ó½Å Àü·« Ȳ±Ý¼º ¸±°ÔÀÓ ¹«·á¹Ù´ÙÀ̾߱â°ÔÀÓ pcºüÂô²¿°ÔÀÓ È²±Ý¼º¸± ¸ð¹ÙÀϰÔÀÓ ¾ß¸¶Åä°ÔÀÓÇϱ†ÇÁ¶ó±×¸¶Æ½ ¹«·áüÇè Ȳ±Ý¼º¾îÇà ¹Ù´ÙÀ̾߱â5¸¸ ¸±°ÔÀÓ´Ù¿î ¿À¼Ç½½·Ô ÁÖ¼Ò ¹«·á°ÔÀÓ´Ù¿î·Îµå ¿À¼ÇÆÄ¶ó´ÙÀ̽º ´Ù¿î ¸±°ÔÀÓȲ±Ý¼º Ȳ±Ý¼º´Ù¿î ¿Â¶óÀξ߸¶Åä°ÔÀÓ ¸ð¹ÙÀϸ±°ÔÀÓ Á¾·ù ¸±°ÔÀÓ¹Ù´ÙÀ̾߱â Ȳ±Ý¼ºÆ÷Ä¿°ÔÀÓ ÀÎÅͳݿ¹½Ã°ÔÀÓ ¹é°æ »ÇºüÀ̳îÀÌÅÍ »ç´Ù¸®°ÔÀÓÁÖ¼Ò ½ºÇɸð¹Ù°ÔÀÓ·£µå ¹Ù´ÙÀÌ¾ß±â°ø·«¹ý ¿Â¶óÀÎ ¾ß¸¶Åä °ÔÀÓ ¾ß¸¶Åä2 ¿Â¶óÀÎ ·±Ã³ ¹Ù´ÙÀ̾߱â¸ÔÆ¢»çÀÌÆ® ¹é°æ°ÔÀÓ¿¹½Ã ÀϺ»ºü¡°í ¹Ù´ÙÀ̾߱â½ÃÁð5 ¾ß¸¶Åä2µ¿¿µ»ó ¸±¿Â¶óÀÎ ¿À¸® Áö³¯¾ß¸¶Å俬Ÿ¿¹½Ã ¿À¼ÇÆÄ¶ó´ÙÀ̽º¸±°ÔÀÓ ÆÄĪÄÚÁ¾·ù ½Ç½Ã°£¸±°ÔÀÓ»çÀÌÆ® ¿Â¶óÀÎ ½½·Ô °ø·« ¸ð¹ÙÀϽÅõÁö¸ð¹ÙÀÏ ´ÙºóÄ¡ ¹Ù´ÙÀ̾߱â»çÀÌÆ® ÀϺ»ºü¡°í ÇÁ¶ó±×¸¶Æ½ ¼øÀ§ ¸±°ÔÀÓ È²±Ý¼º¸±°ÔÀÓ ¿ëÀÇ´«°ÔÀÓ È²±Ý¼º ½½·Ô ¿ìÁÖÀüÇԾ߸¶Åä¸ÔÆ¢ ¹Ù´ÙÀ̾߱â³ë¹«Çö ÀèÆÌ ½Å õÁö °ÔÀÓ ¿À¸®Áö³¯¾ß¸¶Åä2°ÔÀÓ ¿À¼Ç½½·Ô ÀÎÅͳÝȲ±Ý¼º ¹Ù´Ù½Å °ÔÀÓ ¸±°ÔÀÓÇѱ¹ ¾ß¸¶Åä3 ¾ß¸¶Å俹½Ã ½Åõ±â¸±°ÔÀÓ ¿ìÁÖÀüÇԾ߸¶Åä2202 Ȳ±Ý¼º°ÔÀÓ´Ù¿î·Îµå ¹«·á ÃæÀü ¹Ù´ÙÀ̾߱⠸±°ÔÀÓ¼Õ¿À°ø ½½·Ô °ËÁõ»çÀÌÆ® ¸±°ÔÀÓ Á¤º¸ ¿À¼ÇÆÄ¶ó´ÙÀ̽º °ÔÀÓ ¹«·áÃæÀü ¹Ù´ÙÀ̾߱â Ȳ±Ý¼ºµ¿¿µ»ó ½Åõ±â¸±°ÔÀÓ ¸ð¹ÙÀÏ ¾ß¸¶Åä ÀÎÅͳݹٴÙÀ̾߱â°ÔÀÓ È²±Ý¼º°ÔÀÓ¾Û ½½·Ô¸Ó½Å ±â°è ±¸ÀÔ °­¿ø·£µå ½½·Ô¸Ó½Å Çϴ¹ý ¹«·á¾ß¸¶Åä°ÔÀÓ ½Å¿À¼ÇÆÄ¶ó´ÙÀ̽º Ȳ±Ý¼º¹è´çÁÙ ¸±°ÔÀÓ´Ù¿î °­¿ø·£µå ½½·Ô¸Ó½Å Çϴ¹ý ¾ß¸¶Åä2 ¿Â¶óÀÎ ·±Ã³ īī¿À¾ß¸¶Åä¸ÔÆ¢ ¸±°ÔÀÓ Á¤º¸ ½ÅõÁöÀÎÅͳݰÔÀÓ ¾Ë¶óµò¸±°ÔÀÓÀå ¸¶ÀÌÅ©·Î ½½·Ô ¹«·áüÇè ¹Ù´ÙÀ̾߱⠱â°è °¡°Ý ¾Ë¶óµò°ÔÀÓ°ø·«¹ý ¹Ù´ÙÀ̾߱â±â°è ÃֽŸ±°ÔÀÓ ¸±°ÔÀÓȲ±Ý¼º¿À¼Ç¹Ù´Ù ¹Ù´ÙÀ̾߱â Çϴ¹ý ½ÅõÁö¹«·á ¿À¼ÇÆÄ¶ó´ÙÀ̽º °ÔÀÓ È²±Ý¼º°ÔÀÓ¿¹½Ã ¼Õ¿À°ø°ÔÀÓ´Ù¿î ¾Ë¶óµò»çÀÌÆ® ¾ß¸¶Åä°ÔÀÓ ¸±°ÔÀÓ°­½Ã ¹Ù´ÙÀ̾߱â°ÔÀÓ»çÀÌÆ® ¹Ù´ÙÀÌ¾ß±â °í·¡ ÃâÇö ¹Ù´ÙÀ̾߱⠹«·á¸Ó´Ï ¹Ù´ÙÀ̾߱âÇϴ°÷ Ȳ±Ý¼º¿À¶ô½Ç°ÔÀÓ ¹Ù´ÙÀ̾߱â2 Áß°í°ÔÀÓ±â¸Å¸Å ¾ß¸¶Åä2°ÔÀÓÁÖ¼Ò pc¾ß¸¶Åä ¾Ë¶óµò¸±°ÔÀÓÀå ¿À¸®Áö³Î ¹Ù´ÙÀ̾߱⠹«·áÃæÀü ¹Ù´ÙÀ̾߱⠰íÀü¸±°ÔÀÓ È²±Ý¼º°ÔÀÓ·£µå ¹«·áȲ±Ý¼º°ÔÀÓ ¹Ù´ÙÀ̾߱âÇÁ·Î±×·¥ ÇѰÔÀÓÆ÷Ä¿ ¿À¶ô½Ç°ÔÀÓ ÆÄ¶ó´ÙÀ̽º īī¿À¾ß¸¶Åä ÇÏÀ̷οìÇϴ¹ý ¹Ù´ÙÀ̾߱⠿¹½Ã ÆÄĪÄÚ°ÔÀÓ´Ù¿î·Îµå ¸±°ÔÀÓõ±¹ »çÀÌÆ®Ãßõ ¸±°ÔÀÓ ²Ç¸Ó´Ï [Shin-Min Joon, Edaily Reporter] As Trump signs an executive order aiming at lowering price of prescript-xion drugs, Huons announced on May 14 that the company sees limited impact on its core business exports of local anesthetics to the U.S.



Huons CI. (Image=Huons)



According to the White House, U.S. PresidentÅäÇʵå ÁÖ½Ä
Donald Trump signed an executive order on May 12 (local time), ordering officials to communicate with drug manufacturers to offer U.S. consumers most favored-nation pricing.

AccoÁøÈï±â¾÷ ÁÖ½Ä
rding to the fact sheet from the White House, U.S. President Donald Trump¡¯s pharmaceutical innovation was driven by the recent data that the prices U.S. consumers pay for prescript-xion drugs are more t¿Ã½Ó¹Ù
han three times the price OECD member countries (economically advanced countries) pay.
The executive order directed the Secretary of Health and Human Services to establish new target prices ·°Å°¼¼ºì
over the next 30 days and warned to limit government subsidies if drug prices are not significantly lowered.
Huons has obtained seven Food and Drug Administration (FDA) approvals for injectaµ¿¿µ»óȲ±Ý¼º
ble products including sodium chloride injection and lidocaine hydrochloride injection. Recently on May 5th (local time), Huons received its 6th and 7th FDA approvals for 1% and 2% multiple-dose vials of lidocaine hydrochloride injection.
The company¡¯s main product, lidocaine injection, is on the list of essential medicines of the World Health Organization (WHO) and also on the drug shortages list of the FDA.
An official of Huons said ¡°Although restructuring measures on pharmacy benefit manager (PBM) and the target pharmaceutical drugs are not announced yet, we expect the executive order to address drugs with high prices.¡±
He added ¡°The order is expected to have limited impact on our core product, lidocaine injection.¡±
½Å¹ÎÁØ (adonis@edaily.co.kr)


±âÀÚ´Ü ¹× °Ô½ÃÆÇ Áö±â ¸ðÁý GR-·æÀÌ 01-09 6216
ÇöÀç ¾ÆÄ« ¸®Æ÷Æ®´Â.. GR-·æÀÌ 01-09 5424
3390 ÀÇ»ç ó¹æÀü ¾øÀÌ ¾Æµå·¹´Ñ ±¸ÀÔ¡¼rd17.cia158.com¡½Ãßõ ÇØÁؼÛÈ¿ 05-16 24
3389 ·¹ºñÆ®¶ó È¿°ú Áö¼Ó½Ã°£: ¾Ë¾Æ¾ß ÇÒ ¸ðµç °Í - Á¤·Â¿ø free 05-16 253
3388 ¾ç»ê ÇÁ·ÎÄڹРvmfhzhalf free 05-16 87
3387 Ä«¸¶±×¶ó: ³²¼º °Ç°­À» À§ÇÑ »õ·Î¿î ¼±Åà free 05-16 146
3386 ¿À¹ÌÅ©·Ð KP.3 ÀçÀ¯Çà, ÇØ°áÃ¥Àº Æ®¸®¾ÆÀÚºñ¸° - ·¯½Ã¾Æ Á÷±¸ ¿ì¡¦ free 05-16 148
3385 ¾È»ê ºñ¾Æ¸¶ÄÏ ¡¼ vCqq.top ¡½ free 05-16 34
3384 ¡°¼º°ü°è¿¡¼­ ¡®ÀÌ Çൿ¡¯ Çϸé Ä¡¸Å À§Çè ³ô¾ÆÁú ¼ö ÀÖ½À´Ï´Ù¡± free 05-16 35
3383 ¼­±ÍÆ÷ ºñ¾Æ±×¶ó º¹¿ë¹ý ¡¼ vcKk.top ¡½ free 05-16 26
3382 ¹ö¸ñ½º - ¸Þº¥´ÙÁ¹ 100mg x 6Á¤ (À¯·´»ê CÇü ±¸ÃæÁ¦, Ç×¾Ï È¿°ú)¡¦ free 05-16 162
3381 ³²¾çÁÖ Á¶·çÁö¿¬Á¦ - ³²¾çÁÖ Ä¢Ä¢ÀÌ - ³²¾çÁÖ Ä¢Ä¢ÀÌ ±¸¸Å - ¸Ç¡¦ free 05-16 144
3380 ¾ß¸¶Åä°ÔÀÓ ¹æ¹ý ¨¹ 13.rau336.top ¨¹ »óǰ±Ç¸±°ÔÀÓ ÇØÁؼÛÈ¿ 05-16 29
3379 ó¹æÀü ¾øÀÌ ºñ¾Æ±×¶ó ÆÇ¸Å¡¼rd17.cia158.com¡½ ÇØÁؼÛÈ¿ 05-16 27
3378 ¹Ù´ÙÀ̾߱â´Ù¿î·Îµå ¢Ó 30.req598.top ¢Ó ÀÎÅͳݹٴÙÀ̾߱â ÇØÁؼÛÈ¿ 05-16 25
3377 £¨100%Á¤Ç°º¸Àå)¡¼rd17.cia158.com¡½ºñ¾Æ±×¶ó ±¸¸Å Ĭ½ºÅ¸ ±¸¸Å ÇØÁؼÛÈ¿ 05-16 31
3376 ·¹ºñÆ®¶ó ºñ¾Æ±×¶ó Â÷ÀÌ¡¼rd17.cia158.com¡½ ¡¼±¸±Û°Ë»ö:ºñ¾Æxxx¡¦ ÇØÁؼÛÈ¿ 05-16 32
     2001  2002  2003  2004  2005  2006  2007  2008  2009  2010    
±¤°í/Á¦ÈÞ¹®ÀÇ | °ÔÀÓ¸®Æ÷Æ®¶õ? | °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ | ÀÌ¿ë¾à°ü | E-mailÁÖ¼Ò ¹«´Ü¼öÁý±ÝÁö
°ÔÀÓ¸®Æ÷Æ®ÀÇ ¸ðµç ÄÁÅÙÃ÷ ¹× ±â»ç´Â ÀúÀ۱ǹýÀÇ º¸È£¸¦ ¹ÞÀ¸¹Ç·Î ºÒÆßÇÏ¸é ´ë·« ³­°¨!ÇÕ´Ï´Ù. ¤¾¤¾
Copyright 2005.8 °ÔÀÓ¸®Æ÷Æ®, All Rights Reserved
Contact us webmaster@g-report.com